BEAMing	beads, emulsion, amplification, and magnetics
CEA	carcinoembryonic antigen
cfDNA	cell-free DNA
CHIP	clonal hematopoiesis of indeterminate potential
CAN	copy number alteration
CRC	colorectal cancer
CRPC	castration-resistant prostate cancer
CT	computer tomography
ctDNA	cell-tumor DNA
ddPCR	Droplet digital PCR
DFS	disease free survival
EGFR	epidermal growth factor receptor
FDA	Food and Drug Administration
GE	genome equivalent
HR	hazard ratio
indels	small insertions or deletions
MAF	mutant allele fraction
mBC	metastatic breast cancer
mCRC	metastatic colorectal cancer
MRD	minimal residual disease
MSI	microsatellite instability
NGS	Next Generation Sequencing
NSCLC	non-small cell lung cancer
OS	overall survival
PBMCs	peripheral blood mononuclear cells
PFS	progression-free survival
RECIST	Response evaluation criteria in solid tumors
RFI	recurrence-free interval
RFS	recurrence-free survival
SNV	single nucleotide variant
TMB	tumor mutation burden
VAF	variant allele frequency
WBC	white blood cells
WES	whole-exome sequencing